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effectiveness of ionotropic glutamate receptor antagonists in antidyskinetic treatment (Gubellini et al., 2002; Huot et al., 2013; Papa and Chase, 1996) . Amantadine, a drug with antagonistic properties at glutamate N-methyl-d-aspartate (NMDA) receptors, is currently the only medication available in the clinic to control dyskinesia without compromising antiparkinsonian benefit. However, amantadine's pharmacodynamic profile is complex, and its clinical use is limited due to various side effects (Klausberger et al., 2003) . Therefore, in recent years much effort has been put into the development of antidyskinetic approaches based on glutamatergic targets, particularly the metabotropic glutamate receptors (mGluRs). Among the three main subgroups of mGluRs: group I, including mGluR1 and 5; group II, including mGluR2 and 3; and group III, including mGluR4, 6, 7 and 8, mGluR5 has been the most promising candidate for modulation for its interaction with DA D1 receptors (D1R) and NMDR signaling pathways (Litim et al., 2017; Picconi et al., 2018) . However, most of the recent clinical studies of selective antagonists of mGluR5 have reported mixed results of either no anti-dyskinetic effect or adverse effect (Elkouzi et al., 2019) .
An alternative to reduce upregulated glutamate activity could be the modulation of group II mGluR (mGluR2/3), which are located in presynaptic terminals whose activation reduces presynaptic glutamate release in cortical and subcortical regions (Procaccini et al., 2013) . Earlier studies have shown that activation of mGluR2/3 reversed haloperidol-induced catalepsy in rats (Konieczny et al., 1998) and reduced akinesia in reserpine-treated animal models of PD (Murray et al., 2002) . A more recent study also showed that mGluR2/3 agonist-induced long-term depression of excitatory postsynaptic current amplitude in GABAergic substantia nigra pars reticulata (SNr) neurons, which are crucial to the long-term regulation of excitatory transmission in the SNr (Johnson et al., 2011) . More importantly, the mGlu2/3 agonist has been reported to reduce psychotic-like hyperlocomotion induced by phencyclidine and amphetamine (Fell et al., 2008) and could alleviate excessive behavioral hyperactivity of a mouse line lacking the GluA1 subunit of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) glutamate receptor (Procaccini et al., 2013) . These data suggest that mGluR2/3 agonists have motor effects, and possibly, by subtly modulating glutamatergic signaling, they may have a specific anti-dyskinetic effect.
Evaluation of a novel treatment approach requires precise characterization of the normal or diseased states, which could tell how the state is altered by the potential treatments. Fortunately, there are some reliable electrophysiological biomarkers of pathological motor behaviors having been identified within the cortico-basal ganglia network of PD patients and animal models (Cenci et al., 2018; Petersson et al., 2019) . These biomarkers include high β band (hβ, local field potential (LFP) oscillation which is closely related to bradykinesia at OFF state, whereas high γ band J o u r n a l P r e -p r o o f Journal Pre-proof (hγ, oscillation is reliably associated with LID state (Halje et al., 2012; Litim et al., 2017; Tamaru et al., 2001) . Although these findings so far have been successfully translated into development of closed-loop DBS which generates better control of PD symptoms and higher efficiency of DBS device (Little et al., 2013) , the causal relationship between the oscillation and pathological behaviors is still under investigation, and the features of these frequency bands are far from being fully elucidated (Oswal et al., 2013) .
Apart from the changes at a population level, some novel electrophysiological features of LID at a single neuron level also have been reported. Studies have shown that adaptive changes occurred in various signaling mechanisms regulating the function of striatal projection neurons (SPNs).
Segregated populations of SPNs express DA D1 or D2 receptors (D1R or D2R) and form the direct and indirect striatal output pathways, respectively. DA modulates direct and indirect SPNs oppositely, it is excitatory on the D1R-direct pathway and inhibitory on D2R-indirect pathway neurons.
However, it is reported that the responses of SPN to DA were conserved in PD but became unstable in advanced PD with LID (Liang et al., 2008; Singh et al., 2015) . In advanced parkinsonian primates, dopaminergic stimulation-induced unstable firing rate changes in SPNs that were associated with LID, whereas DA responses were significantly stabilized across SPNs after blocking glutamate inputs on the recorded neurons (Singh et al., 2018) . These results support a primary role of glutamate dysregulation in dysfunctional SPN responses to DA and the associated motor behavior. Whether the unstable response of SPN to DA is also correlated to the rodent abnormal involuntary movements (AIMs, the rodent equivalent to the primate LID) remains unknown. If this pathological phenomenon could be reproduced in rodents, the measure can provide a tool to explore the potential effect of mGluR2/3 agonists on pathological SPN responses to DA with correlated effects on dyskinesias.
In this study, we collected behavioral and electrophysiological data in the primary motor cortex (M1) and dorsolateral striatum (DLS) of freely moving 6-OHDA-lesioned rats during L-DOPA priming. By analyzing the LFP oscillation, spike-field coherence, spike-LFP phase-locking, and single-neuron activity and correlated them with the behaviors, we tried to profile the cortico-striatal network dysregulation and to investigate the impact of acute glutamatergic manipulations by amantadine and LY354740 on established AIMs. Collectively, our results show that the development firmly attached to the skull for electrode anchoring, and an additional ground wire was connected to one of them for reference. At the end of the surgery, the whole electrode array was secured with dental cement, and a layer of antibiotic ointment was applied to the cut area. Neuronal activity can be recorded as early as a week after the surgery. A total of fifteen hemiparkinsonian rats and three intact rats were successfully implanted with electrodes and used in the following experiments.
AIMs rating
AIMs of rodents were a group of topographically-classified movements, including axial, limb, and orofacial (ALO) dyskinesia, which resembled the LID in human or primate. For quantification, rats were observed and scored for 1 min every 20 min for a total 140 min following treatment of L-DOPA (12 mg/kg + benserazide 6 mg/kg, i.p., Sigma-Aldrich) using a validated AIMs scale (Lundblad et al., 2004; Winkler et al., 2002) . Each of these three subtypes was scored on a scale from 0 to 4: 0 = absent; 1 = occasional, present during less than half min; 2 = frequent, present during more than half min; 3 = continuous but interrupted by strong sensory distraction; 4 = continuous, not disrupted by strong sensory distraction. All the scores were assessed by an experienced researcher who was unaware of the treatment of animals, while the behaviors of animals were recorded simultaneously using a video camera for necessary reviews.
L-DOPA priming and drugs treatments
About three weeks (-24 day) before the L-DOPA treatment and electrophysiological recordings, rats were successively lesioned with 6-OHDA, tested with apomorphine (-10 day), and implanted with microelectrodes (-7 day). During the L-DOPA priming period, fifteen hemiparkinsonian rats were subjected to L-DOPA (12 mg/kg + benserazide 6 mg/kg, i.p.) administration daily for one week to induce stable LID, which was accompanied by ALO AIMs scores and electrophysiological data recorded on the first (D1) and the last day (D7). Then, rats were randomly treated with amantadine Error bars denote SEM. (C) Schematics illustrated the positions of recording electrodes targeting the primary motor cortex (M1) and dorsolateral striatum (DLS). The SD rat brain slices were modified from Bao, X., Shu, S., 1991. The stereotaxic atlas of the rat brain. People's Medical Publishing House. (D) At about 24 days before the electrophysiological recording (-24 day), animals received 6-OHDA injection into the right medial forebrain bundle and were screened by apomorphine-induced rotation test two weeks later (-10 day). The microelectrodes were implanted three days after the confirmation of the lesion (-7 day). One week later, 6-OHDA-lesioned animals were injected with L-DOPA (12 mg/kg + benserazide 6 mg/kg, i.p.) daily for one week (D1 to D7) to induce stable L-DOPA-induced dyskinesia (LID). Then animals were randomly allocated to the cross-over experiment to examine the acute impact of pretreatment of amantadine 60 mg/kg (AMAN) and LY354740 12 mg/kg (LY) to the L-DOPA-induced AIMs with one day between each experiment as a wash-out ("WO"). In vivo electrophysiological recordings and ALO AIMs scores assessment ("R + B") were conducted simultaneously during each experiment. extracted with a high-pass (300 Hz) and low-pass (200 Hz) filters, respectively. Real-time spike sorting was performed using principal component analysis (PCA). LFP was downsampled to 1 kHz.
At the beginning of each recording session, animals were allowed to adapt to the recording chamber for 5 min, followed by a recording of the free moving state for 10 min in a separate data file.
Continuous electrophysiological data was then collected following L-DOPA administration until AIMs diminished spontaneously (usually ~ 140 min).
LFP power analysis
LFP in M1 and DLS was assessed using NeuroExplorer 5.107 software (Nex Technologies, Littleton, MA) as previously described with modification (Li et al., 2012) . Briefly, LFP recordings from channels with exceptional noises or movement artifacts were excluded. As a result, 7.2 ± 0.4 channels per experiment in M1 and 6.5 ± 0.4 channels per experiment in DLS were included. Then spectrograms were generated by normalizing continuous data as the log of power spectral density (PSD) from 0.5 to 200 Hz, calculated using the multitaper method with a time-bandwidth product of 3 and a number of tapers of 5, shifting with 50% window overlap. The frequency block was set at 512 at 2 Hz resolution. 50 Hz noise was removed from the spectrogram. The mean of power in a specific frequency band was obtained by averaging PSD time series of 180 s each, representatives of different observation window of the spectrograms over that frequency band, such as high β (hβ, 20-40 Hz) and high γ (hγ, 80-110 Hz) frequency band.
Single-unit spike sorting and classification
Single-unit spike sorting was performed with Off-Line Spike Sorter 2.8.5 software (Plexon Inc., Dallas, TX, USA) using a combination of automatic and manual sorting techniques. The first three principal components of all waveforms recorded from each channel were depicted in 3-dimensional (3D) space. Automatic clustering techniques (standard expectation maximization method) were used to produce an initial separation of waveforms into individual clusters. Each cluster was then checked manually to ensure that the cluster boundaries were well separated and spike waveforms were consistent. SPNs, tonically-active interneurons (TANs) and fast-spiking interneurons (FSIs) in the peak-to-valley time; high average firing rates ( Fig. S1 ).
Neuron firing pattern analysis
Spike trains of 180 s at a minimum, representative of three states (OFF, ON, and LID) without visible noise were used for calculation of firing rates binned at 1 sec. Average firing rate of unit at OFF state (the period of time following the L-DOPA injection when L-DOPA had not worked, indicated by the presence of hβ oscillation band in the LFP spectrum), ON state (the period when L-DOPA took effect and LID had not appeared, marked by the attenuation or disappearance of hβ oscillation and absence of hγ oscillation), and LID state (the period featured with AIMs and stable hγ oscillation) were compared. The responses of SPN to DA were determined by the change of firing rates of two adjacent states. A stable response was such that the direction of firing rate change from ON to LID was the same to one from the OFF to ON, i.e., both increased or decreased; the unstable response was such that the direction of firing rate change from ON to LID was opposite to the one from OFF to ON. For instance, a neuron with unstable response increased its activity from OFF to ON but decreased the firing when LID began (Liang et al., 2008; Singh et al., 2018) . Since this study mainly focused on the neurons responding to DA, the units with no significant firing rate changes from OFF to ON state (mean firing rate comparison p > 0.05), i.e., no response to DA were excluded from further analysis. The spike power spectrograms were normalized that the sum of all the spectrum values is equal to the mean squared value of the rate histogram, calculating raw PSD from 0.5 to 20 Hz using multitaper method with a time-bandwidth product of 3 and a number of tapers of 5, shifting with 50% window overlap. The frequency block was set at 128 at 0.3 Hz resolution.
The fluctuation of high γ oscillation
To quantify the novel feature, the fluctuation of hγ oscillation during LID state, the high-power oscillation band within 80-110 Hz shown in LFP spectrogram was roughly regarded as a short signal, of which the amplitude, phase and power relationships of various frequency components could be resolved via transforming the time domain into frequency domain by a Fourier transform. The amplitudes of different frequency components characterized the fluctuations: a signal with more low-frequency components generally displayed wave-like or large saw-tooth shape, i.e., higher fluctuation, whereas the one with less low-frequency components usually displayed smooth shape and small serrated edge, i.e., relatively higher stability. The calculation was as follows: First, the LFP spectrogram of each experiment was derived at the same time scale using NeuroExplorer. Next, the lower-side contour of the hγ band was extracted using MATLAB R2017a (Math-Works) and is J o u r n a l P r e -p r o o f Journal Pre-proof transformed by the fast Fourier transform (FFT) to obtain the frequency spectrum of this two-dimensional curve. We defined the area under the curve (AUC) from 0.0002 Hz to 0.03 Hz as the "fluctuation of hγ oscillation" to quantify this feature. The frequency range selected for calculation was arbitrary but effective for illustrating this issue.
Coherence analysis
Spike-field coherence analysis was used to assess the strength of the phase/amplitude association between the firing rates of units and simultaneously-recorded LFP. The coherence spectrum of SPNs to the noise-free LFP data recorded in the M1 was analyzed using NeuroExplorer. Briefly, coherence was calculated using the multitaper method with a time-bandwidth product of 3 and a number of tapers of 5, shifting with a 50% window overlap. The frequency block was set at 256 at 0.78 Hz resolution. For better illustration, we further calculated the AUC of the coherence spectrum between 80-110 Hz and defined this parameter as the "hγ coherence value" for the comparison between groups.
Analysis of phase-locked firing and circular statistics
To demonstrate how the activity of SPNs involved in abnormal oscillation, the instantaneous phase relationships between striatal spike times and striatal hγ oscillations were analyzed using NeuroExplorer and MATLAB as modified methods described previously (Klausberger et al., 2003; Sharott et al., 2017) . First, episodes of hγ oscillation were detected using "Find Oscillations" analysis in NeuroExplorer by calculating the frequency power ratio of hγ (80-110 Hz) to a band with relatively constant power (120-140 Hz) in 2-second windows. A ratio greater than the minimum ratio (usually 3-4) in at least three consecutive windows marked hγ episodes. Once the oscillatory epochs were identified, the continuous variable was band-filtered (80-110 Hz, third-order Butterworth filters) within these epochs. Hilbert transform was then applied to the filtered signal. The transform of the phase of the Hilbert transform from 360° to 0° was identified as the start of the oscillation cycles. In this formalism, peaks in the striatal hγ oscillations correspond to a phase of 180° and troughs to a phase of 0°. Next, in the "Firing Phase" analysis, the phase histogram was calculated with histogram bin counts divided by the number of spikes in all oscillation cycles in a bin number of 30. The preferred phase of each unit was defined as the phase with the highest peak in the histogram (Csicsvari et al., 1999) . Then, circular-phase plots and circular statistical measures were calculated using the CircStat toolbox (Berens, 2009 ) for MATLAB. The mean resultant vector length of phase values for each spike (0-1, the closer to 1, the more concentrated the angles) was used to quantify the J o u r n a l P r e -p r o o f Journal Pre-proof level of phase-locking around the mean phase for populations of neurons. A unit preferentially fired around a mean locked phase was defined as one fired within the range of mean angle ± 90°.
Histology
Animals were deeply anesthetized and transcardially perfused with saline, followed by 4% paraformaldehyde (PFA) in 0.1 M PBS (pH 7.4). Brains were dissected and fixed in 4% PFA overnight at 4°C. After fixation, tissues were transferred to 70% ethanol and processed for paraffin sectioning (4 μm/section) at M1, DLS, and substantia nigra compact (SNc). Then sections were mounted on glass slides, deparaffinized by xylene, dehydrated in graded ethanol solutions, baked in the basic antigen retrieval buffer (pH = 6.0), and washed with phosphate buffer (pH 7.4). The sections of the striatum were processed by tyrosine hydroxylase (TH) (1:750, Abcam, ab112) immunohistochemistry. Sections were blocked with 3% bovine serum albumin and then incubated with the diluted primary antibody in a humidified chamber overnight at 4°C. Sections were washed and subsequently incubated with biotinylated goat anti-rabbit IgG, then HRP labeled streptavidin fluid, followed by DAB solutions, counterstained with Harris hematoxylin, dehydrated in graded ethanol solutions, and eventually covered with coverslips. Images were collected through an Olympus camera connected to the microscope at the same light intensity, and the integrated optical density (IOD) of TH-positive terminals in the striatum was calculated using the ImageJ software.
Briefly, immunochemical images were transformed into 8-bit type (gray) and calibrated using "Uncalibrate OD". Then, positive-signals were selected via adjusting thresholds manually. The integrated density (IOD) was then calculated with the "Measure" plugin of ImageJ.
Statistical analysis
All statistical analyses were performed in SPSS 21.0 software. Two-tailed Student's t test was performed to compare two independent groups. ANOVA followed by post hoc Bonferroni test was used for multiple comparisons among groups, and was indicated by F value unless otherwise specified. Kruskal-Wallis test with Dunn's multiple comparison test was used to compare the coherence value of SPNs to hγ oscillation. Rayleigh's uniformity test was used to examine the significance of phase-locking. Watson-Williams F test was used to compare the differences in the mean phase angles of groups of neurons. Pearson's χ 2 test was used for comparisons of proportions.
Pearson correlation was used to calculate the correlation between two parameters. The significance level was set at p < 0.05. Data are presented as mean ± SEM. 
L-DOPA treatment-induced stable AIMs and abnormal LFP oscillations in 6-OHDA-lesioned rats
We first examined the influence of L-DOPA priming, i.e., repeated L-DOPA (12 mg/kg + benserazide 6 mg/kg, i.p.) treatment on the motor behaviors of L-DOPA-naïve 6-OHDA-lesioned rats. On the first day of L-DOPA-priming (D1), animals exhibited various levels of AIMs, but merely 3 of 15 showed full AIMs score (12.0') at the peak of L-DOPA effect (60 min after L-DOPA injection). On the 7 th day (D7), all the animals displayed a stable LID state with full AIMs scores from 20 min to at least 100 min ( Fig. 2A) . Accordingly, the total 140-min AIMs scores increased significantly from D1 to D7 (26.9 ± 2.0' and 65.3 ± 1.6' respectively, p < 0.0001, Fig. 2B ). Moreover, the axial score, which characterized the axially twist of body, was the lowest among the three AIMs sub-items scores on D1 (55.2% and 49.6% lower than oral and limb respectively, F = 12.5, p < 0.0001, ANOVA), whereas the difference among them decreased on D7 (12.3% lower, p = 0.16, Fig.   2C ).
Next, consistent with the previous study, we observed the abnormal high β band (hβ, oscillation at OFF state characterized by bradykinesia, as well as the high γ band (hγ, oscillation at LID state featured with AIMs, which were both absent under intact conditions ( Fig.   2D ). Besides, the powers of both hβ and hγ oscillation were both much higher in M1 than in DLS (52.1% and 86.0% lower, p < 0.001, t test), mainly due to the difference of two structures both in depth (Li et al., 2012) and in cellular constitution that the highly aligned pyramidal cell provides a better chance for synchronous current flows in the same direction as compared to the striatum (Herreras, 2016) . In line with the previous studies (Dupre et al., 2016; Halje et al., 2012) , The time-dependent changes of the powers of hγ oscillation mirrored the profiles of AIMs, confirming that the hγ oscillation is a reliable indicator of the intensity of AIMs. Besides, at the end of LID (140 min), the powers of re-emerged hβ oscillation were a few higher than the one at the beginning (0 min) ( Fig. 2E) , which may be attributed to higher motility post LID, whereas animals were usually at rest after the injection of L-DOPA (Dupre et al., 2016) . 
L-DOPA treatment advanced LID and decreased fluctuation of high γ oscillation in 6-OHDA-lesioned rats
Given that the ON state, a transient state between OFF and LID state that was free from both parkinsonian and dyskinetic symptoms, was hard to assess in the rodent model, we visualized hβ and hγ oscillation by constructing LFP spectrograms to estimate the start and end of the OFF and LID state in each experiment (Fig. 3A) . On D1, the time interval between the end of hβ band and the start of hγ band (ON state) was 9.1 ± 2.2 min, while on D7, LID began much earlier (16.2 ± 1.1 min vs.
26.5 ± 0.9 min, p < 0.0001, t test), and the ON duration shortened to merely 1.62 ± 1.6 min (p = J o u r n a l P r e -p r o o f Journal Pre-proof 0.012, t test), which is a prominent manifestation of L-DOPA priming (Fig. 3B) . Besides, we also observed some intriguing phenomena in LFP spectrograms. First, there was a "switch" between hβ and hγ oscillation near the end of LID, i.e., OFF state and LID state appeared alternatively when LID gradually vanished (Fig. 3A, black box) . Second, we observed the discontinuity in the middle of the hγ band, which was not accompanied by the presence of hβ (Fig. 3A, arrowhead) . Both phenomena indicated the instability of hγ oscillation or LID state, while the only difference was that the "switch" was specific to the end of LID and was mostly found on D7, whereas the interrupt of hγ oscillation was only observed on D1. Third, we found that the hγ oscillation was not a smooth and homogeneous band, which instead was full of wave-or sawtooth-like fluctuation (Fig. 3A) .
Generally, the hγ band on D1 displayed wave-like shape, whereas on D7 was relatively more smooth and only exhibited large fluctuations at the end of the LID. Therefore, the shape of the hγ oscillation band may also reflect the stability of the LID state. Accordingly, we quantified the fluctuations by viewing the hγ band as a signal composed of different frequencies, which could be extracted by means of signal analysis and expressed as a frequency spectrum ( Fig. 3C) . We defined the "fluctuation of hγ oscillation" as the AUC from 0.0002 Hz to 0.03 Hz in the frequency spectrum. As expected, the average fluctuation of hγ oscillation was higher on D1 than on D7 (p = 0.043, t test), especially at lower frequency range (Fig. 3C , the grey area), which explained the wave-like shape of hγ oscillation on D1 (Fig. 3D) . These findings suggest that L-DOPA priming induced and stabilized AIMs in 6-OHDA-lesioned rats, which could be dynamically demonstrated by the distinct features of hγ oscillation. 
L-DOPA treatment increased the coherence and phase-locking of SPNs to high γ oscillation in 6-OHDA-lesioned rats
We next examined the behavior-physiological associations at the level of single neurons. The strength of coupling between spike and LFP at any given frequency, known as spike-field coherence, helps to illustrate how the individual neuron is involved in oscillation. In this study, we found that the one-week repeated treatment of L-DOPA induced a significantly high coherence of SPNs at the hγ range (p < 0.001, Kruskal-Wallis test, Fig. 4A, B) , whereas the SPNs in the intact rats showed no coherence around 80-110 Hz. Also, we further quantified the temporal relationship between the hγ oscillations and the spike firing of SPNs via phase-locked firing analysis, which could separate the effects of amplitude and phase. Here we selected LFP data recorded in DLS instead of M1 to achieve a more stable correlation (Sharott et al., 2017) .
The results showed that SPNs in 6-OHDA-lesioned rats, but not those in intact rats, exhibited a higher probability of discharging around the troughs of the DLS hγ oscillations, and the strength was more evident on D7 than on D1 (Fig. 4C) . SPNs in intact rats showed no clear or consistent preference for any phase angle of the hγ oscillations. In contrast, on D1 and D7, the mean angle of firing (phase) of SPNs was closer to the trough of the hγ oscillation and the population vector length (magnitude) was also longer (mean firing angle: 275.37 ± 19.8°, population vector length: 0.26, p = 0.025, F = 5.1 vs. D1; p < 0.0001, F = 24.6 vs. D7, Watson-Williams F test), suggesting a significant phase-locking and a preference to fire around the hγ oscillation troughs of SPNs after L-DOPA priming (Fig. 4D) . Furthermore, 75.0% of SPNs fired preferentially at the troughs of an angle range of 360 ± 90° On D1, and the proportion increased to 94.9% on D7 (p < 0.0001 vs. D1, Pearson's χ 2 ), whereas in intact rats, only 52.1% of neurons showed the same preference (p = 0.0016 vs. D1, p < 0.0001 vs. D7, Pearson's χ 2 , Fig. 4E ). Collectively, these results suggest that L-DOPA increased the phase-locking of the firing of SPNs to the hγ oscillation after L-DOPA priming. 
The proportion of unstable SPN responses to DA increased after repeated L-DOPA treatment
Previous studies in advanced parkinsonian primates have shown that dopaminergic stimulation induces LID-related unstable firing rate changes in SPNs (Liang et al., 2008; Singh et al., 2018; Singh et al., 2015) , which however has never been verified in other PD animal models. The response to DA was determined by comparing the firing rate of one state with its prior state in such a way that "↑↑" J o u r n a l P r e -p r o o f Journal Pre-proof and "↓↓" denoted stable responses, whereas "↓↑" and "↑↓" denoted unstable responses (Singh et al., 2018) . For instance, "↓↑" is a response that the firing rate of a unit decreased from OFF state to ON state but then increased when LID began (Fig. 5A) . The units without obvious firing rate changes from OFF to ON state (mean firing rate comparison, p > 0.05), i.e., with no response to DA, were excluded from further analysis. On D1, stable responses took up the larger part of SPNs (66.3%), which was roughly equally split between "↑↑" and "↓↓", whereas on D7, the proportion of "↑↑" maintained but "↓↓" significantly decreased (14.7%, p = 0.0086, Pearson's χ 2 ) and "↓↑" increased from 17.4% to 30.5% (p = 0.032, Pearson's χ 2 ). In consequence, there were more SPNs exhibited unstable responses on D7 (49.4%, p = 0.0259, Pearson's χ 2 , Fig. 5B ). Furthermore, we found that "↑↑" response on D7 displayed a significantly greater change of firing rates (% of OFF) from OFF to LID state than on D1 (p = 0.024, t test, Fig. 5C ). Collectively, the increased unstable responses, especially "↑↓" type, together with elevated firing rates of "↑↑" may contribute to the progress of LID. Responses of SPNs to DA were determined based on comparing the change of firing rates from OFF to ON to the change from ON to LID: "↑↑" and "↓↓" denoted stable responses, whereas "↓↑" and "↑↓" 
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Acute pretreatment of amantadine or LY354740 alleviated AIMs and related abnormal LFP oscillations in LID rats
Having characterized the LID-associated electrophysiological changes, we next examined the effect of two glutamate manipulating approaches in the LID rats model. After one-week L-DOPA priming, rats exhibited stable LID (n = 15) were pretreated i.p. 100 min before L-DOPA (12 mg/kg + benserazide 6 mg/kg, i.p.) with amantadine 60 mg/kg (AMAN), or a mGluR2/3 agonist, LY 354740 12 mg/kg (LY) in a cross-over manner that each rat received acute treatment of AMAN and LY with one-day washout. The sequence of AMAN and LY was set randomly to eliminate the potential influence of the treatment sequence. The LID-associated behavioral and electrophysiological changes with different pretreatments were compared with their counterpart on D7 (denoted as "L-DOPA").
In line with previous studies (Bido et al., 2011; Lundblad et al., 2002) , AMAN significantly reduced AIMs scores from the very beginning of the LID, and only 2 of 15 animals reached full scores at 60 min (7.7 ± 0.6' vs. 12.0 ± 0.0' of L-DOPA, p < 0.0001, F = 13.9) (Fig. 6A) . In contrast, LY did not show an apparent alleviating effect on the strength of LID at peak (10.3 ± 0.4', p = 0.15).
However, it was interesting to find that LY caused a dramatic drop of AIMs scores at 100 min (4.7 ± 0.9'), whereas neither L-DOPA nor AMAN induced termination of LID until 120 min (6.7 ± 1.1' and 4.4 ± 0.6' respectively vs. 0.6 ± 0.4' of LY, p = 0.0086, F = 6.1), suggesting that LY significantly reduced the duration of LID. Accordingly, AMAN significantly reduced the total scores by 52% (p < 0.0001, F = 125.4), whereas although behaving not as effectively as AMAN at the peak of LID, LY also decreased the total scores by 31% (p < 0.0001, Fig. 6B ). AIMs subitem scores were evenly reduced by AMAN and LY, suggesting that L-DOPA priming established a relatively stable behavior pattern of AIMs, which were not altered by the two pretreatments ( Fig. 6C) . Besides, Consistent with the previous study, we also observed side effects caused by AMAN, such as irritation and eye edema (Tronci et al., 2014) . the observations in Fig. 2E , the power of hβ oscillation showed an opposite changing profile to the one of hγ oscillation that higher power of hγ oscillation was coupled with lower powers of hβ oscillation. Accordingly, we found negative linearity between hβ and hγ power in the data pooled from all experiments (Fig. 6F) . Altogether, AMAN alleviated the intensity of LID, whereas LY exhibited a weak anti-dyskinetic effect at the peak effect of L-DOPA but shortened the duration of LID. 
Acute pretreatment of amantadine or LY354740 altered the duration of LID and fluctuation of high γ oscillation
In line with the behavioral observations, LY shortened the LID duration (87.1 ± 1.8 min vs 99.5 ± 3.0 min of L-DOPA, p = 0.0104, F = 28.8) and terminated LID at 106.2 ± 2.3 min (p = 0.034 vs 115.6 ± 2.6 min of D7, F = 38.3). Moreover, to our surprise, AMAN significantly prolonged the duration of LID (118.6 ± 2.8 min, p < 0.0001), and ceased LID at 136.9 ± 1.5 min (p < 0.0001).
Besides, it was noteworthy that the restart of OFF was earlier than the termination of LID in three groups, especially AMAN, because we marked the "start of hβ" once the hβ oscillation reappeared even intermittently during the "switch" mentioned above (Fig. 7A, black box) . This result suggests that the circuits that generate or maintain the hβ or hγ oscillation respectively may be relatively independent (Fig. 7B, C) .
Similarly, we found that AMAN showed relatively more significant sawtooth vibration, whereas L-DOPA and LY were relatively more smooth. As expected, AMAN increased the overall amplitudes of frequency in frequency spectrum of hγ band, especially at lower frequency part (Fig. 7D) , and induced higher fluctuation of hγ (p = 0.012, F = 24.1), whereas LY further decreased the fluctuation of hγ by 21.8% (p = 0.0039), reflecting a more smooth and steady LID state (Fig. 7E) . As a consequence, we found a significantly positive correlation between the fluctuation of hγ and the duration of hγ when pooling data across L-DOPA, AMAN and LY group (Fig. 7F) . In contrast, the same relationship on D1 was opposite, featured by larger fluctuation of hγ corresponding to shorter hγ duration (Fig. 7G) . This finding suggests that higher fluctuation of hγ, i.e., less stable LID state, is generally coupled with a longer duration of hγ oscillation or LID in the animals with established LID. 
J o u r n a l P r e -p r o o f
Amantadine reduced the proportion of SPNs that were phase-locking to high γ oscillation in LID rats
We then examined the correlation of the single unit with the hγ oscillation and found that average hγ coherence values were comparable among L-DOPA, AMAN and LY (p = 0.37, Kruskal-Wallis test), however, it is intriguing to observe that LY shifted the coherence peak frequency of to a higher frequency though of no significance (98.4 ± 10.9 Hz vs. 93.1 ± 8.1 Hz and 93.6 ± 12.7 Hz of L-DOPA and AMAN, respectively, p = 0.03, F = 2.6, Fig. 8A, B) . This peak frequency shift phenomenon was supported by examining the location of hγ band in LFP spectrogram (Fig. 3A, Fig. 5A, Fig. 7A and Fig. 9A ). Furthermore, we assessed the spike firing phases of SPNs with respect to hγ oscillations. The results showed that AMAN and LY did not alter the tendency of SPNs to discharge around the troughs of DLS hγ oscillations (Fig. 8C) , and the average angle of firing and the population vector length were also comparable among three groups (Fig. 8D) . Nevertheless, AMAN significantly reduced the proportion of SPNs fired preferentially around troughs of the angle (360 ± 90°) to 86.2% (p = 0.043 vs. 94.9% of L-DOPA, Pearson's χ 2 ), whereas LY had no such effect (93.9%, p = 0.80, Pearson's χ 2 ) (Fig. 8E) . Collectively, these results suggest that AMAN reduced the amount of phase-locking SPNs. led to the elevation of the stable response from 50.5% to 67.1% (p = 0.024, Pearson's χ 2 ). Although of no significance, LY also increased the stable responses in SPNs (57.6%, p = 0.38, Pearson's χ 2 , Fig. 9B ). Next, we calculated the absolute total change of the rate of each group from the algebraic addition (stable groups) or subtraction (unstable groups) of the rate differences between each motor state and the previous one. The result showed that AMAN tended to decreased the total change of firing rates (%) from OFF to LID state in both unstable groups, and the stable group of "↓↓" response (p > 0.05), whereas LY exerted no obvious influence on the total change of firing rates (Fig. 9C) . In summary, AMAN increased the proportion of stable response of SPNs to DA, decreased the change of firing rates among states, which may be correlated with the attenuation of LID. 
Discussion
Glutamatergic overexcitability is a critical player in the development of LID; however, the anti-dyskinetic effect of manipulation of mGluR2/3 that could reduce the glutamate release from the pre-synaptic terminals has been uncertain. In this study, we established the stable in vivo electrophysiological recording system in 6-OHDA-lesioned hemiparkinsonian rats and triggered LID-like behaviors via a one-week repeated L-DOPA treatment. By giving amantadine or the mGluR2/3 selective agonist, LY354740 before the injection of L-DOPA, we demonstrated that the typical anti-dyskinetic agent, amantadine alleviated AIMs scores, intensity, and stability of abnormal hγ oscillation, synchronized firing and unstable responses of SPNs to DA. In contrast, mGluR2/3 selective agonist, LY354740, significantly shortened the duration of LID but exerted a weak beneficial effect on alleviating the intensity of LID at peak effect and associated electrophysiological dysregulations. Therefore, the distinct mechanisms underlying the impact of different glutamate manipulating approaches remain to be further explored.
"Switch" between hβ and hγ oscillation suggests the independence of circuits sustained each oscillation
"Priming" is classically defined as the process by which the brain becomes sensitized and maintains its primed state via the repeated treatment of dopaminergic therapy (Brotchie, 2005;  J o u r n a l P r e -p r o o f Journal Pre-proof Nadjar et al., 2009 ). In agreement with other studies (Bido et al., 2011; Dupre et al., 2016) and our previous studies (Chen et al., 2017; Zheng et al., 2018) , the present results showed that one-week treatment of L-DOPA (12 mg/kg + benserazide 6 mg/kg, i.p., daily) is an efficient and steady dosage regimen to induce full and stable LID in unilaterally-lesioned rats. Narrow-band hγ oscillation is a reliable biomarker of dyskinesia (Oswal et al., 2013; Petersson et al., 2019) . Consistently, we observed the typical 80-110 Hz γ oscillation in the lesioned-side M1 and DLS of rats during LID, and as LID developing after repeated L-DOPA treatments, the power of hγ oscillation increased and correlated positively with AIMs scores, i.e., the intensity of LID.
We also observed two phenomena associated with the instability of the LID state, which has been reported (Dupre et al., 2016; Halje et al., 2012) . The first one is the discontinuity at the middle of the hγ oscillation, which was only observed on the first day of priming in this study. It could be both spontaneous (due to immature LID state) and pharmacologically-induced (anti-dyskinetic agents) (Dupre et al., 2016) . The second one is the "switch" between hβ and hγ oscillation near the end of the LID, which was usually observed in animals with established LID and relatively long AIMs. Since pretreatment of AMAN generally induced long-lasting AIMs in the study, this phenomenon was also more common in this group. Halje et al. once showed a very similar phenomenon induced by D1R antagonist in LID rats (Halje et al., 2012) . However, the intermittent appearance of LID and a concurrent switch-back of hγ oscillation in their study was not coupled with the presence of hβ oscillation, which thus is not the "switch" observed in this study. Nevertheless, it should be noted that the "switch" appeared at the end of LID, whereas the intermittence of hγ oscillation presented by Halje et al. was at the middle of the LID due to the drug administration time.
It is predictable that if the timing of the drug is near the end of LID, similar "switch" may also be observed. Taken these two phenomenon together, it is rational to infer that the "switch" may be a superimposed phenomenon of the intermittent appearance of hγ oscillation due to the desynchronization and the reappearance of hβ oscillation due to the vanishment of L-DOPA effect, which means that the origins and involved circuits of these two oscillations may be relatively independent. In support of this, there are several differences between hβ and hγ oscillation. First, hβ oscillation is state-dependent and is generally suppressed when the subject is active (De Hemptinne et al., 2015) , whereas narrowband hγ is unaffected by the actuation of voluntary movements (Swann et al., 2016) . Second, experimental findings suggest that aberrant hβ oscillation may originate intrinsically in the striatum, whereas hγ oscillation is generated in the cortical network or driven by the thalamus. If it is the case, it would not be surprising to see hβ oscillation "cuts in line" when it is time for it to play while hγ oscillation has not exited. Collectively, our observation of the "switch" 
The fluctuation of hγ oscillation revealed different anti-dyskinetic effects of amantadine and LY354740
Another intriguing finding relevant to the stability of hγ oscillation is the new indicator we defined in this study, the fluctuation of hγ oscillation. The idea of defining this indicator originated from the findings that AMAN prolonged the duration of LID, whereas LY significantly reduced LID duration. Notably, the hγ oscillation bands of AMAN group were featured with saw-tooth-like fluctuation, similar to the ones on the first day of priming, whereas the ones in the LY group were smoother. These observations led to the assumption that the stability of hγ oscillation may be correlated with the duration of the LID. Thus, we quantified this phenomenon by transformed the hγ oscillation band by FFT into the frequency spectrum and defined the AUC of the spectrum as the fluctuation of hγ oscillation. As expected, there is a positive correlation between the fluctuation of hγ and the LID duration, i.e., the higher fluctuation is coupled with longer LID duration. As the fluctuation can also be regarded as a kind of instability, the reason why unstable hγ is coupled with longer LID and stable hγ is related to shorter LID is unclear. More importantly, It should be noted that the LID-prolonging effect of amantadine or the LID-shortening effect of LY354740 has never been demonstrated before (Bido et al., 2011; Lundblad et al., 2002) .
There are some possible explanations for the effect of amantadine. First, the different dosage regimen, especially the dose of benserazide, of each study generates different duration of LID, which may pharmacokinetically influence the effect of amantadine. Second, in PD patients, amantadine increased the duration of ON state, which is associated with both decreased duration of dyskinesia and prolonged effect of L-DOPA (Luginger et al., 2000; Metman et al., 1998; Thomas et al., 2004) .
The ON state in patients is a period free from LID or with very weak LID manifestations, whereas we usually cannot reproduce the LID-release effect in patients to the same extent in the rodent model due to the high dose of L-DOPA whose effect is hard to be completely eliminated by even the large and side-effect-evoked dose of amantadine (60 mg/kg). . As a consequence, although the anti-dyskinetic effect of amantadine is significant in the rodent model, there is no such amantadine-induced ON state in the rodent model, and the LID period is so-called "prolonged" if amantadine facilitates the effect of L-DOPA and shortens the OFF state. Nevertheless, this finding should be further examined in the future using different dosage regimens of L-DOPA and amantadine.
As for LY354740, We noted that the LY354740 peak frequency of hγ oscillation was shifted to a J o u r n a l P r e -p r o o f Journal Pre-proof higher level when compared with L-DOPA and AMAN, revealed both by the LFP spectrogram and coherence spectrum. Although of no significance, the shift of the peak frequency is a specific manifestation of LY354740, which may be related to its LID-shortening effect. However, since there is no previous evidence supporting such a phenomenon, related mechanisms need to be further demonstrated, and we also provide possible explanations in the last section of the discussion.
The possible role of dysregulation of SPNs in the LID development
The previous study has revealed that cells in lesioned-side M1 and DLS of hemiparkinsonian rats showed robust spike-LFP phase-locking, i.e., neural activity is clearly entrained to LFP oscillations in the hγ range (70-110 Hz) in the dyskinetic state (Dupre et al., 2016; Halje et al., 2012) .
In line with that, we also found that lesioned-side SPNs exhibited a clear tendency to discharge around the troughs of the hγ oscillations during LID, which was not presented in the intact rats. It should be noted that there is no such hγ oscillation in the intact rats and thus it is conceivable that the coherence or phase-locking of SPNs relative to the hγ range is much lower than that in lesioned rats.
However, since a negative correlation between the hγ power and the phase-locking of neurons has been reported (Dupre et al., 2016) , i.e., lower hγ power is coupled with higher phase-locking, it is still necessary to confirm that there is no such situation in the intact rats. Nevertheless, it would be more meaningful to examine the phase-locking in the intact hemisphere of lesioned rats, which, however, was not conducted due to the limitation of this study. Furthermore, it was once demonstrated that GABAergic SPNs of the indirect pathway in the DA-depleted striatum were hyperactive, excessively synchronized, and tend to discharge around the troughs of cortical β oscillations (15-30 Hz), which led to GABAergic external globus pallidus (GPe) neurons hypoactive and anomalously firing around the peaks of cortical beta oscillations (Sharott et al., 2017 ). As we were not able to determine the types of SPNs recorded in this study, further studies are needed to define the role of different subtypes of SPNs in hγ oscillations.
According to the classic direct/indirect pathway model of cortico-basal ganglia network, the SPNs associated with the direct pathway (dSPNs) that facilitated movement was inhibited under the parkinsonian condition at OFF state and was activated at ON state, whereas SPNs in the movement-inhibiting indirect pathway (iSPNs) is the opposite. However, this model has been challenged in these years due to the findings that SPNs of both pathways joined hands in movement initiation (Calabresi et al., 2014) . Recently, by using a novel retrograde labeling method, a study also demonstrated two clusters in dSPNs with different morphology, intrinsic excitability and, J o u r n a l P r e -p r o o f Journal Pre-proof FosB/ΔFosB preference following continuous L-DOPA treatment in 6-OHDA-lesioned rats (Fieblinger et al., 2018) . Although how the dynamic segregation of the SPNs relates to the occurrence and manifestation of LID is unknown, our study provides a possible explanation for the constitutional changes of SPNs.
The unstable response of SPNs to DA is first found and defined by Liang et al. in the study of advanced parkinsonian monkeys (Liang et al., 2008) . They found that the activities associated with the recovery of mobility (firing rate increased or decreased) of a group SPNs were subsequently inverted when LID occurred, suggesting that these bidirectional changes, i.e., unstable response of SPNs were associated with LID (Liang et al., 2008; Singh et al., 2015) . Later the same research group showed that responses of SPNs to DA were stabilized after blocking glutamatergic inputs, which highlighted the critical role of both dysregulated glutamatergic pathway and dysfunctional SPNs in LID (Singh et al., 2018) . It is once uncertain whether the acute and unilateral LID modeling in rodents could induce the unstable responses of SPNs to DA, which are originally found in primates that have a slowly-and bilaterally-induced parkinsonism (Singh et al., 2018) . Indeed, the duration of the ON states in rats (~ 2 min) was much shorter than that in primates (~10 min); however, we did observe a large group of SPNs exhibited unstable responses in lesioned DLS, and the proportion of the SPNs with unstable responses to DA increased as the LID developed and could be reduced by amantadine. Thus, these results verify the findings in primates and demonstrate for the first time that the proportion of unstable responses of SPNs to DA has an indicative function in reflecting the intensity of LID in the LID rodent model.
Taken together, we propose that as long-term depression (LTD) lost after repeated L-DOPA treatments, a group of SPNs, whether in direct or indirect pathway, "betray" their respective proto-states (maintain increased or decreased activities) and begin unstably acting in such a way that they invert their firing rates when the concentration of DA in striatum elevates to a certain level.
Such a group of SPNs could not carry out their original jobs as expected, and when the proportion of the SPNs with the unstable response to DA is large enough, they may interfere with the normal activity and finally induce the abnormal involuntary movements, i.e., LID. Accordingly, via blocking the glutamate signaling and other pathways, amantadine reduces both the proportion of unstable SPNs, thus alleviated LID and partially restored the normal action of animals. Nevertheless, to verify this hypothesis requires determining the identity of the SPNs with the unstable response to DA, which is a challenging but intriguing issue worth addressing in the future.
Anti-dyskinetic effect of mGluR2/3 manipulation is still inconclusive
J o u r n a l P r e -p r o o f
Over-active excitatory glutamate signaling is one of the key players in driving the developing of LID, supported by the facts that NMDA receptor noncompetitive antagonists, amantadine and memantine both have been proved effective in alleviating LID in both patients and animal models (Sawada et al., 2010; Tronci et al., 2014; Wictorin and Widner, 2016) . However, the side effects of amantadine lead to the exploration of other glutamate signaling modulation approaches, especially the manipulation of metabotropic glutamate receptors (Bradley et al., 2000; Marino et al., 2002) .
Among the subgroups of mGluRs, mGluR5 has been the most promising candidate for modulation, but the recent clinical studies of the selective antagonist of mGluR5 reported mixed results (Elkouzi et al., 2019) . Therefore, other manipulating approaches are investigated. It is reported that activation of Group II mGluRs (mGluR2/3) pre-synaptically located on corticostriatal fibers inhibits glutamate release by inhibiting AC-cAMP-PKA pathway, in the same way, it inhibits the excitatory drive of subthalamic nucleus (STN), which is also directly involved in the development of LID, onto the basal ganglia output nuclei (Conn et al., 2005; Tamaru et al., 2001) . Thus, it is believed that mGluR2/3 agonists could modulate glutamate-mediated excitatory transmission in striatum and STN via lowering the glutamate level. In support of this, systemic and striatal administrated 5-HT1AR agonist ±8-OH-DPAT attenuated L-DOPA-induced dyskinesia and striatal glutamate efflux via activation of these receptors, which is also located pre-synaptically on corticostriatal glutamatergic neurons and could attenuate the release of glutamate into the striatum (Dupre et al., 2011) . Besides, mGluR2/3 agonists also enhance post-synaptic excitatory receptor function, including both AMPARs and NMDARs, by regulating several intracellular pathways (Li et al., 2015) . Taken together, it is possible that through pre-synaptically reduced glutamate release and post-synaptically enhanced glutamate receptor function, mGluR2/3 agonists can modulate synaptic transmission and reset the balance of synaptic activity to a new "normal" condition.
Of note, the systemic injection of mGluR2/3 agonist, LY379268 in the LID rat model failed to ameliorate either AIM scores or molecular markers of LID in the striatum, possibly because DA depletion increased the potency of mGluR2/3 agonists in inhibiting excitatory transmission at cortico-striatal synapses, while decreasing the ability of the same drug to inhibit excitatory transmission at the STN-SNr synapse (Gubellini et al., 2017) . Consistently, the anti-peak-dyskinetic effect of systemically injected LY354740 was also weak in our study. However, we did observe an impressing reproducible shortening of the duration of LID induced by LY354740, which lowered the total ALO AIM scores. This duration-reducing effect was similar to the observations of memantine in human patients (Wictorin and Widner, 2016) . One of the possible explanations of the effect of J o u r n a l P r e -p r o o f LY354740 is its role in the modulation of DA levels. It is said that extrasynaptic glutamate can suppress DA release by interacting with mGluR2/3 receptors on nigrostriatal terminals; thus mGluR2/3 agonists are supposed to reduce the level of DA in the striatum (Baker et al., 2002) . Thus, LY354740 may advance the occurrence and termination of LID via quickly exhausting the DA pool through facilitating DA release. However, systemic injection of LY379268 enhances DA release in the striatum, leaving the overall effect of mGluR2/3 agonists in regulating dopaminergic function unclear (Conn et al., 2005) . Nevertheless, in contrast to the orthostatic acting agonists, mGlu2R positive allosteric modulators (PAMs) have a unique state-dependent mode of action to modulate excessive synaptic glutamate release while exerting little effect on normal or basal release (Fell et al., 2012; Gasparini et al., 2013) , which may be able to eliminate the discrepancy of effect among different sites in BG when faced with DA depletion.
Conclusion
This study demonstrated that in the 6-OHDA-lesioned hemiparkinsonian rats, the typical anti-dyskinetic agent, amantadine alleviated AIMs scores, strength, and stability of abnormal hγ oscillation, synchronized firing, and unstable responses of SPNs to DA. In contrast, mGluR2/3 selective agonist, LY354740 significantly shortened the duration of LID but exerted a weak beneficial effect in diminishing intensity of LID at peak effect and alleviating associated electrophysiological dysregulations. Therefore, further investigations regarding the anti-dyskinetic effect of manipulating mGluR2/3 are needed, and the distinct mechanisms underlying the effect of different glutamate manipulating approaches remain to be further explored.
